WallStreetZenWallStreetZen

NASDAQ: STTK
Shattuck Labs Inc Stock

$7.49+0.00 (+0%)
Updated May 24, 2024
STTK Price
$7.49
Fair Value Price
$1.77
Market Cap
$356.16M
52 Week Low
$1.33
52 Week High
$11.76
P/E
-3.88x
P/B
2.76x
P/S
166.51x
PEG
N/A
Dividend Yield
N/A
Revenue
$2.72M
Earnings
-$85.08M
Gross Margin
100%
Operating Margin
-3,133.63%
Profit Margin
-3,133.6%
Debt to Equity
0.14
Operating Cash Flow
-$71M
Beta
1.17
Next Earnings
Jun 7, 2024
Ex-Dividend
N/A
Next Dividend
N/A

STTK Overview

Shattuck Labs Incorporated is a clinical-stage biotechnology company developing bi-functional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune diseases. The company's lead program, SL-172154, designed to block the CD47 immune checkpoint and simultaneously agonize the CD40 pathway, is undergoing a Phase 1 trial. A second compound, SL-279252, is being evaluated in a Phase 1 trial in collaboration with Takeda Pharmaceuticals. Shattuck Labs was incorporated in 2016 and is headquartered in Austin, TX.

Zen Score

Industry Average (22)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how STTK scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

STTK ($7.49) is overvalued by 322.94% relative to our estimate of its Fair Value price of $1.77 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
STTK ($7.49) is not significantly undervalued (322.94%) relative to our estimate of its Fair Value price of $1.77 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
STTK is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more STTK due diligence checks available for Premium users.

Be the first to know about important STTK news, forecast changes, insider trades & much more!

STTK News

Valuation

STTK fair value

Fair Value of STTK stock based on Discounted Cash Flow (DCF)
Price
$7.49
Fair Value
$1.77
Overvalued by
322.94%
STTK ($7.49) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
STTK ($7.49) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
STTK is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

STTK price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-3.88x
Industry
15.58x
Market
32.03x

STTK price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
2.76x
Industry
6.08x
STTK is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

STTK's financial health

Profit margin

Revenue
$1.1M
Net Income
-$18.5M
Profit Margin
-1,659.6%
STTK's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
STTK's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$146.3M
Liabilities
$17.5M
Debt to equity
0.14
STTK's short-term assets ($131.08M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
STTK's short-term assets ($131.08M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
STTK's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$16.2M
Investing
-$33.3M
Financing
-$184.0k
STTK's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

STTK vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
STTK$356.16M0.00%-3.88x2.76x
TNYA$356.47M+4.13%-2.77x2.25x
GUTS$357.31M-1.32%N/A4.24x
JSPR$360.85M+0.42%-4.26x3.19x
ACIU$351.16M-0.84%-5.28x2.21x

Shattuck Labs Stock FAQ

What is Shattuck Labs's quote symbol?

(NASDAQ: STTK) Shattuck Labs trades on the NASDAQ under the ticker symbol STTK. Shattuck Labs stock quotes can also be displayed as NASDAQ: STTK.

If you're new to stock investing, here's how to buy Shattuck Labs stock.

What is the 52 week high and low for Shattuck Labs (NASDAQ: STTK)?

(NASDAQ: STTK) Shattuck Labs's 52-week high was $11.76, and its 52-week low was $1.33. It is currently -36.31% from its 52-week high and 463.16% from its 52-week low.

How much is Shattuck Labs stock worth today?

(NASDAQ: STTK) Shattuck Labs currently has 47,550,872 outstanding shares. With Shattuck Labs stock trading at $7.49 per share, the total value of Shattuck Labs stock (market capitalization) is $356.16M.

Shattuck Labs stock was originally listed at a price of $19.35 in Oct 9, 2020. If you had invested in Shattuck Labs stock at $19.35, your return over the last 3 years would have been -61.29%, for an annualized return of -27.12% (not including any dividends or dividend reinvestments).

How much is Shattuck Labs's stock price per share?

(NASDAQ: STTK) Shattuck Labs stock price per share is $7.49 today (as of May 24, 2024).

What is Shattuck Labs's Market Cap?

(NASDAQ: STTK) Shattuck Labs's market cap is $356.16M, as of May 25, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Shattuck Labs's market cap is calculated by multiplying STTK's current stock price of $7.49 by STTK's total outstanding shares of 47,550,872.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.